MCA
BMY icon

Midwest Capital Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Midwest Capital Advisors’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.64K Hold
150
– – ﹤0.01% 173
2026
Q1 		$9.1K Hold
150
– – ﹤0.01% 168
2025
Q4 		$8.09K Buy
+150
New +$7.22K ﹤0.01% 164

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Midwest Capital Advisors's BMY Position: Q2 2026 in Review

Midwest Capital Advisors held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 150 shares worth $8.64K. The position accounts for ﹤0.01% of the portfolio, ranked #173.

Midwest Capital Advisors first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. The position peaked at $9.1K in Q1 2026. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Midwest Capital Advisors held 150 shares of Bristol-Myers Squibb worth $8.64K as of Q2 2026.
  • Midwest Capital Advisors left its Bristol-Myers Squibb share count unchanged in Q2 2026.
  • Bristol-Myers Squibb made up ﹤0.01% of Midwest Capital Advisors's portfolio in Q2 2026, its #173 holding.
  • Midwest Capital Advisors first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
  • Midwest Capital Advisors's Bristol-Myers Squibb position peaked at $9.1K in Q1 2026.
  • 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Midwest Capital Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.